| Name | Title | Contact Details |
|---|
Abbey Delray South is part of Lifespace Communities, Inc., a not-for-profit, multistate system of senior living communities that currently serves more than 5,100 people. For more than 40 years, Lifespace has created beautiful spaces for seniors to thrive and celebrate life every day. With decades of success and financial stability under its belt, Lifespace has earned national respect and recognition and, even more importantly, the trust of thousands of team members, residents and their families.
Marathon Health is based in Indianapolis, IN and Winooski, VT. When we say we are a different kind of healthcare company, we mean we`re a better kind. What makes us better is that we guide people to take control of their own health. We operate on a simple premise: when people are given the tools they need to manage their own health and healthcare, the cost of healthcare is lower. We believe the best way to keep people healthy is to help them manage risk factors and chronic conditions, and to keep them from getting sick in the first place. To do this, we combine a powerful collection of onsite health services into a program tailored to your unique culture, setting, and workforce.
Paid Claims is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Glendive Medical Center Inc. is a Glendive, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III